Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jason B. White"'
Autor:
Chengyue Wu, Angela M. Jarrett, Zijian Zhou, Nabil Elshafeey, Beatriz E. Adrada, Rosalind P. Candelaria, Rania M.M. Mohamed, Medine Boge, Lei Huo, Jason B. White, Debu Tripathy, Vicente Valero, Jennifer K. Litton, Clinton Yam, Jong Bum Son, Jingfei Ma, Gaiane M. Rauch, Thomas E. Yankeelov
Publikováno v:
Cancer Res
Triple-negative breast cancer (TNBC) is persistently refractory to therapy, and methods to improve targeting and evaluation of responses to therapy in this disease are needed. Here, we integrate quantitative MRI data with biologically based mathemati
Autor:
Rosalind P. Candelaria, Beatriz E. Adrada, Deanna L. Lane, Gaiane M. Rauch, Stacy L. Moulder, Alastair M. Thompson, Roland L. Bassett, Elsa M. Arribas, Huong T. Le-Petross, Jessica W.T. Leung, David A. Spak, Elizabeth E. Ravenberg, Jason B. White, Vicente Valero, Wei T. Yang
Publikováno v:
Ultrasound Med Biol
This study aimed to investigate mid-treatment breast tumor ultrasound characteristics that may predict eventual pathologic complete response (pCR) in triple-negative breast cancer; specifically, we examined associations between pCR and two parameters
Autor:
Clinton Yam, Nour Abuhadra, Ryan Sun, Beatriz E. Adrada, Qing-Qing Ding, Jason B. White, Elizabeth E. Ravenberg, Alyson R. Clayborn, Vicente Valero, Debu Tripathy, Senthilkumar Damodaran, Banu K. Arun, Jennifer K. Litton, Naoto T. Ueno, Rashmi K. Murthy, Bora Lim, Luis Baez, Xiaoxian Li, Aman U. Buzdar, Gabriel N. Hortobagyi, Alistair M. Thompson, Elizabeth A. Mittendorf, Gaiane M. Rauch, Rosalind P. Candelaria, Lei Huo, Stacy L. Moulder, Jeffrey T. Chang
Publikováno v:
Clin Cancer Res
Purpose:Metaplastic breast cancer (MpBC) is a rare subtype of breast cancer that is commonly triple-negative and poorly responsive to neoadjuvant therapy in retrospective studies.Experimental Design:To better define clinical outcomes and correlates o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::338df94510fedde500728928d4f7d9fc
https://europepmc.org/articles/PMC9250637/
https://europepmc.org/articles/PMC9250637/
Autor:
Peng Wei, Wei T. Yang, Lumarie Santiago, Marion E. Scoggins, Rosalind P. Candelaria, Alastair M. Thompson, Gary J. Whitman, Beatriz E. Adrada, Tanya W. Moseley, Jason B White, Vicente Valero, Stacy L. Moulder, Elizabeth Ravenberg, Jennifer K. Litton, Gaiane M. Rauch
Publikováno v:
Cancer
BACKGROUND Heterogeneity exists in the response of triple-negative breast cancer (TNBC) to standard anthracycline (AC)/taxane-based neoadjuvant systemic therapy (NAST), with 40% to 50% of patients having a pathologic complete response (pCR) to therap
Autor:
Benjamin C. Musall, Beatriz E. Adrada, Rosalind P. Candelaria, Rania M. M. Mohamed, Abeer H. Abdelhafez, Jong Bum Son, Jia Sun, Lumarie Santiago, Gary J. Whitman, Tanya W. Moseley, Marion E. Scoggins, Hagar S. Mahmoud, Jason B. White, Ken‐Pin Hwang, Nabil A. Elshafeey, Medine Boge, Shu Zhang, Jennifer K. Litton, Vicente Valero, Debu Tripathy, Alastair M. Thompson, Clinton Yam, Peng Wei, Stacy L. Moulder, Mark D. Pagel, Wei T. Yang, Jingfei Ma, Gaiane M. Rauch
Publikováno v:
Journal of magnetic resonance imaging : JMRIReferences. 56(6)
Pathologic complete response (pCR) to neoadjuvant systemic therapy (NAST) in triple-negative breast cancer (TNBC) is a strong predictor of patient survival. Edema in the peritumoral region (PTR) has been reported to be a negative prognostic factor in
Autor:
Lei Huo, Gaiane M. Rauch, Alyson Clayborn, Tanbin Rahman, Pamela McCarthy, David Ramirez, Elizabeth Ravenberg, Sadia Saleem, Stacy L. Moulder, Clinton Yam, W. Fraser Symmans, Jason B White, James Stec, Sausan Abouharb, Bora Lim, Jennifer K. Litton, Senthil Damodaran, Meghan Sri Karuturi, Ryan Sun
Publikováno v:
Investigational New Drugs. 39:509-515
Folate receptor alpha (FRα) has been reported to be expressed in up to 80% of triple-negative breast cancers (TNBC) with limited expression in normal tissues, making it a promising therapeutic target. Mirvetuximab soravtansine (mirvetuximab-s) is an
Autor:
Jessica W.T. Leung, Rosalind P. Candelaria, Jong Bum Son, Elsa Arribas, Peng Wei, Hagar S. Mahmoud, Jingfei Ma, Marion E. Scoggins, Kenneth R. Hess, Jennifer K. Litton, Abeer H Abdelhafez, Stacy L. Moulder, Vicente Valero, Elizabeth Ravenberg, Alastair M. Thompson, Gary J. Whitman, Huong T. Le-Petross, Beatriz E. Adrada, Tanya W. Moseley, Mark D. Pagel, Gaiane M. Rauch, Deanna L. Lane, Benjamin C. Musall, Ken Pin Hwang, Jason B White, Lumarie Santiago, Wei T. Yang
Publikováno v:
Breast Cancer Res Treat
PURPOSE: To determine if tumor necrosis by pretreatment breast MRI and its quantitative imaging characteristics are associated with response to NAST in TNBC. METHODS: This retrospective study included 85 TNBC patients (mean age 51.8 ± 13 years) with
Publikováno v:
Journal of strength and conditioning research. 36(2)
Ishida, A, Travis, SK, Draper, G, White, JB, and Stone, MH. Player position affects relationship between internal and external training loads during Division I collegiate female soccer season. J Strength Cond Res 36(2): 513-517, 2022-The purpose of t
Autor:
Rosalind P. Candelaria, Stacy L. Moulder, A David, Shu Zhang, Hagar S. Mahmoud, Huong T. Le-Petross, Deanna L. Lane, Mark D. Pagel, Ken Pin Hwang, Gaiane M. Rauch, Beatriz E. Adrada, Jingfei Ma, Jia Sun, Nabil Elshafeey, Alastair M. Thompson, Jong Bum Son, Peng Wei, Elizabeth Ravenberg, Elsa Arribas, Jason B White, Wei T. Yang, Jessica W.T. Leung, Rania M.M Mohamed, Abeer H Abdelhafez, Benjamin C. Musall, Senthil Damodaran, Jennifer K. Litton, Medine Boge
Publikováno v:
Journal of magnetic resonance imaging : JMRIReferences. 54(1)
BACKGROUND Dynamic contrast-enhanced (DCE) MRI is useful for diagnosis and assessment of treatment response in breast cancer. Fast DCE MRI offers a higher sampling rate of contrast enhancement curves in comparison to conventional DCE MRI, potentially
Autor:
Timothy P. Heffernan, Ningping Feng, Jason B White, Jeffrey T. Chang, Xiao Yan Ma, Yizheng Tu, W. Fraser Symmans, Virginia Giuliani, Shirong Cai, Xuan Liu, Clifford Stephan, Xinhui Zhou, Reid T. Powell, Lei Guo, Joseph R. Marszalek, Christopher P. Vellano, Abena B. Redwood, Stacy L. Moulder, Helen Piwnica-Worms, Peter J.A. Davies, Yuan Qi, Gloria V. Echeverria, Yan Jiang, Xiaomei Zhang
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports
Scientific Reports
Triple-negative breast cancer (TNBC) accounts for 15–20% of breast cancer cases in the United States, lacks targeted therapeutic options, and is associated with a 40–80% risk of recurrence. Thus, identifying actionable targets in treatment-naïve